Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review. 2014

Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
Department of Oral Mucosa Diseases, University of Medical Sciences, Bukowska 70, 60-812, Poznan, Poland, zuzia_slebioda@o2.pl.

Recurrent aphthous stomatitis (RAS; recurrent aphthous ulcers; canker sores) belongs to the group of chronic, inflammatory, ulcerative diseases of the oral mucosa. Up to now, the etiopathogenesis of this condition remains unclear; it is, however, considered to be multifactorial. The results of currently performed studies indicate that genetically mediated disturbances of the innate and acquired immunity play an important role in the disease development. Factors that modify the immunologic response in RAS include: food allergies, vitamin and microelement deficiencies, hormonal and gastrointestinal disorders (e.g., celiac disease, Crohn's disease, ulcerative colitis), some viral and bacterial infections, mechanical injuries and stress. In this paper, we presented the main etiopathogenetic factors of RAS with a special emphasis on the mechanisms of the immune response modification. Moreover, we discussed the crucial clinical symptoms and types of RAS together with epidemiologic data based on the current medical literature reports and our own observations.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013281 Stomatitis, Aphthous A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742) Aphthae,Canker Sore,Periadenitis Mucosa Necrotica Recurrens,Ulcer, Aphthous,Aphthous Stomatitides,Aphthous Stomatitis,Aphthous Ulcer,Aphthous Ulcers,Canker Sores,Sore, Canker,Sores, Canker,Stomatitides, Aphthous,Ulcers, Aphthous
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
D056747 Immunomodulation Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances. Immunomodulatory Therapy,Immunomodulations,Immunomodulatory Therapies,Therapies, Immunomodulatory,Therapy, Immunomodulatory

Related Publications

Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
July 1982, The Journal of the American Osteopathic Association,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
April 2014, Journal of clinical and experimental dentistry,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
October 1986, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
April 1978, Czasopismo stomatologiczne,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
November 1989, Dental Cadmos,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
January 2000, Minerva stomatologica,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
September 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
March 2017, The Journal of clinical and aesthetic dermatology,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
September 2007, Journal of the European Academy of Dermatology and Venereology : JEADV,
Zuzanna Slebioda, and Elżbieta Szponar, and Anna Kowalska
October 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
Copied contents to your clipboard!